How to Read a 22q11.2 Deletion Genetic Test Report
At a Glance
A 22q11.2 deletion syndrome genetic test report shows the exact location and size of missing DNA on chromosome 22. While the report identifies missing critical genes like TBX1, the deletion size does not predict the severity of symptoms, so comprehensive medical evaluations are essential.
When you first receive your or your child’s genetic test report, it can feel like trying to read a foreign language. The string of numbers and letters on a Chromosomal Microarray Analysis (CMA) is simply a highly detailed map showing exactly where a tiny piece of DNA is missing on chromosome 22 [1]. (Note: If you had a FISH test, it acts more like a targeted “yes/no” check for the deletion and uses different shorthand [2]). Breaking down the microarray’s genetic “zip code” can help you understand the boundaries of the deletion and advocate effectively for care, even though the exact size of the deletion cannot perfectly predict which symptoms will occur [3][4].
Breaking Down the Genetic Code
Most microarray reports will list a result that looks something like this: arr[GRCh37] 22q11.21(18,648,855-21,505,417)x1. Here is what each part of that code means [5][1]:
- arr: Stands for “microarray,” which is the advanced technology used to scan the DNA for missing or extra pieces.
- [GRCh37]: This is the “map version” or reference genome used by the lab to locate the missing DNA (you might also see hg19 or GRCh38). Different versions will change the exact coordinate numbers, but the physical deletion remains the same.
- 22q11.21: This is the specific address. It means the deletion is on chromosome 22, on the long arm (indicated by “q”), in region 11.21.
- (18,648,855-21,505,417): These are the deletion coordinates. They mark the exact starting and ending points of the missing DNA segment.
- x1: This indicates the copy number. We usually have two copies of every gene (one from each parent). The “x1” (or sometimes “del”) means there is only one copy instead of two—confirming a deletion.
Deletion Size: 3 Megabases vs. 1.5 Megabases
By subtracting the starting coordinate from the ending coordinate, specialists calculate the deletion size. For example, in the coordinates above, subtracting 18,648,855 from 21,505,417 equals 2,856,562—or roughly 2.85 million base pairs.
About 85% to 90% of individuals with this syndrome have this “typical” deletion that is roughly 3 Megabases (Mb) long, meaning they are missing about 3 million DNA letters [6][7].
Some individuals have smaller “nested” or atypical deletions, often around 1.5 Megabases [6][7]. However, because the most critical genes are located in the region shared by both the 3 Mb and 1.5 Mb deletions, the overall size of the deletion does not strictly dictate how severe the syndrome will be [6][3]. Two people with the exact same deletion size can have very different medical needs [8][4].
Missing Genes You Should Know
Within that deleted segment of DNA are dozens of genes. Knowing the boundaries of the deletion helps geneticists know which specific genes are missing [1]. Important genes often discussed include:
- TBX1: This is the major gene responsible for many of the physical features of the syndrome. It plays a critical role in how the heart, aorta, palate (roof of the mouth), and throat structures form during early pregnancy [9][10][11].
- Other critical genes: The typically deleted region also contains genes like COMT and PRODH, which researchers study for their links to neurodevelopmental delays, learning challenges, and psychiatric risks (such as an increased risk for schizophrenia) [4][10].
If the deletion is “typical” and includes TBX1, it can also impact the development of the thymus gland, leading to lower levels of T-cells (white blood cells that fight infection) [12]. This means there may be a higher risk for infections. Research notes that rare, atypical deletions that sit further down the chromosome (distal deletions) and exclude TBX1 tend to have better T-cell counts [12][13].
Ultimately, because this is a complex multisystem condition, the care team will rely on thorough, multidisciplinary medical evaluations—checking the heart, calcium levels, immune system, and development—not just the genetic report to guide personalized treatment [8][14].
Common questions in this guide
What does the string of letters and numbers on my microarray report mean?
Does the size of the 22q11.2 deletion predict how severe symptoms will be?
What is the TBX1 gene and why is it important?
What is a typical deletion size for 22q11.2 deletion syndrome?
Which specialists should we see after receiving a 22q11.2 deletion diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What map version (like GRCh37 or GRCh38) was used for this microarray, and what are the exact starting and ending coordinates of the deletion?
- 2.Based on these coordinates, does the deletion include the TBX1 gene and the typical 3 Megabase region?
- 3.Are there any other missing genes or genetic changes noted on the report outside of the 22q11.2 region that we should be aware of?
- 4.Knowing the size and location of this deletion, which specific specialists (like cardiology, immunology, or endocrinology) should we see for baseline screening?
- 5.Can you provide a copy of the actual laboratory report for my records so I have the exact nomenclature to share with other specialists?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Experiences in microarray-based evaluation of developmental disabilities and congenital anomalies.
Ozyilmaz B, Kirbiyik O, Koc A, et al.
Clinical genetics 2017; (92(4)):372-379 doi:10.1111/cge.12978.
PMID: 28128450 - 2
Inverted duplication, triplication and quintuplication through sequential breakage-fusion-bridge events induced by a terminal deletion at 5p in a case of spontaneous abortion.
Chai H, Grommisch B, DiAdamo A, et al.
Molecular genetics & genomic medicine 2019; (7(10)):e00965 doi:10.1002/mgg3.965.
PMID: 31478360 - 3
Chromosome 22q11.2 Deletion Syndrome: A Comprehensive Review of Molecular Genetics in the Context of Multidisciplinary Clinical Approach.
Szczawińska-Popłonyk A, Schwartzmann E, Chmara Z, et al.
International journal of molecular sciences 2023; (24(9)) doi:10.3390/ijms24098317.
PMID: 37176024 - 4
Neurobiological perspective of 22q11.2 deletion syndrome.
Zinkstok JR, Boot E, Bassett AS, et al.
The lancet. Psychiatry 2019; (6(11)):951-960 doi:10.1016/S2215-0366(19)30076-8.
PMID: 31395526 - 5
De Novo Interstitial Deletion of 9q in a Pediatric Patient With Global Developmental Delay.
Keselman D, Singh R, Cohen N, Fefer Z
Child neurology open 2019; (6()):2329048X19844920 doi:10.1177/2329048X19844920.
PMID: 31106228 - 6
Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.
Zhao Y, Guo T, Fiksinski A, et al.
American journal of medical genetics. Part A 2018; (176(10)):2172-2181 doi:10.1002/ajmg.a.40359.
PMID: 30289625 - 7
Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
Bevilacqua E, Jani JC, Chaoui R, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2021; (58(4)):597-602 doi:10.1002/uog.23699.
PMID: 34090308 - 8
Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
Kuo CY, Signer R, Saitta SC
Current allergy and asthma reports 2018; (18(12)):75 doi:10.1007/s11882-018-0823-5.
PMID: 30377837 - 9
Single-cell transcriptomics uncovers a non-autonomous Tbx1-dependent genetic program controlling cardiac neural crest cell development.
De Bono C, Liu Y, Ferrena A, et al.
Nature communications 2023; (14(1)):1551 doi:10.1038/s41467-023-37015-9.
PMID: 36941249 - 10
Six at Sixty. 'Have you tested for 22q?'
Scambler P
Journal of medical genetics 2025; (62(2)):147-149 doi:10.1136/jmg-2024-110504.
PMID: 39837658 - 11
A case report of T-box 1 mutation causing phenotypic features of chromosome 22q11.2 deletion syndrome.
Haddad RA, Clines GA, Wyckoff JA
Clinical diabetes and endocrinology 2019; (5()):13 doi:10.1186/s40842-019-0087-6.
PMID: 31428446 - 12
Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.
Crowley B, Ruffner M, McDonald McGinn DM, Sullivan KE
American journal of medical genetics. Part A 2018; (176(10)):2082-2086 doi:10.1002/ajmg.a.38597.
PMID: 29341423 - 13
Candidate modifier genes for immune function in 22q11.2 deletion syndrome.
Pinnaro CT, Henry T, Major HJ, et al.
Molecular genetics & genomic medicine 2020; (8(1)):e1057 doi:10.1002/mgg3.1057.
PMID: 31830774 - 14
The 22q11.2 deletion syndrome: Genetic mechanisms, clinical manifestations, and therapeutic strategies.
Yang S, Zhuang Y, Xin S, et al.
Clinica chimica acta; international journal of clinical chemistry 2026; (586()):120893 doi:10.1016/j.cca.2026.120893.
PMID: 41690495
This page is for educational purposes to help you understand your genetic test report. Always consult your genetic counselor or medical geneticist for interpretation of your specific results and care planning.
Get notified when new evidence is published on 22q11.2 deletion syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.